๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group Study

โœ Scribed by Osborne, C.K.; Weiss, G.R.; Blumenstein, B.A.; Crawford, E.D.; Bukowski, R.M.; Larrimer, N.R.

Book ID
121981441
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
210 KB
Volume
28
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II evaluation of mitoxantrone in a
Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study
โœ Sarah A. Taylor; Thomas Fleming; Daniel D. Hoff; Joseph D. McCracken; Ronald M. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 242 KB

Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or equal to 1.5 mg% received mitoxantrone 12 mg/m2 i.v

Phase II evaluation of bleomycin. A Sout
Phase II evaluation of bleomycin. A Southwest Oncology Group study
โœ Charles D. Haas; Charles A. Coltman Jr.; Jeffrey A. Gottlieb; Arthur Haut; James ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 369 KB ๐Ÿ‘ 2 views

Bleomycin given intravenously (i.v.) or intramuscularly (i.m.) in twice-weekly doses of 10 mg/mz was evaluated for efficacy and toxicity in 382 patients. Responses were observed in 11/27 Hodgkin's diseases, 10/30 lymphomas, 9/22 squamous cell cancers of ectodermal origin, 12/26 germinal cancers, and